Search CMS Open Payments to see what drug and device manufacturers paid U.S. prescribers.
Open Payments is a federal program run by the Centers for Medicare & Medicaid Services (CMS). It collects and publishes information about payments that drug and medical device companies make to physicians and teaching hospitals.
Payments include consulting fees, research grants, travel and lodging, food and beverage, speaking fees, royalties, and ownership interests — any transfer of value over $10.
Financial relationships aren't inherently problematic, but transparency helps patients and policymakers understand potential influences on prescribing decisions and medical research.
Each drug profile on Know Your Drugs Institute includes an Open Payments section when data is available. It shows the total value of payments reported by that drug's manufacturer in a given program year.
We currently surface figures from CMS Program Year 2023 — the most recent reporting year published by CMS (released June 2024). Industry-wide, manufacturers reported roughly $12.75B in payments to physicians and teaching hospitals that year.
We don't editorialize or assign judgment — we surface the numbers as reported to CMS so you can factor them into your own conversations with your healthcare provider.
Search Open Payments directly on CMS.gov. Look up a medication from Search to see reported manufacturer payments on its profile.
Loading full data from Know Your Drugs Institute…